Which of the two fits US HCP campaigns?

PulsePoint when endemic inventory from the WebMD family counts. DeepIntent when the evidence hangs on prescription-adjacent metrics via partners such as Crossix. Both demand managed proximity and US contract logic, and neither offers self-serve.

Can PulsePoint or DeepIntent be used in DACH?

Not viably. Both data models rest on US registers and US health-data partners with no local equivalent. Local healthcare reach comes from professional portals plus area signals, legal review per deployment included.

Healthcare Media

PulsePoint vs DeepIntent: Two US Healthcare DSPs, One Duel

Both buy programmatically on US health data. The difference sits in the foundation: endemic inventory against a measurement ecosystem.

Healthcare Media Activation Audit →To the healthcare media comparison

Short verdict

PulsePoint

Take PulsePoint when the endemic environment is what decides it.

US HCP campaigns with endemic inventory from the WebMD family.
Global pharma setups that separate US and EU data paths cleanly.

DeepIntent

Take DeepIntent when the evidence hangs on the prescription.

US campaigns with HCP or DTC focus, run from a global media setup.
Pharma teams using US-specific healthcare measurement partners.

Both expect managed proximity and US contract logic, neither offers self-serve. For DACH neither carries: person-level health targeting on the US model is not lawful here. Assessment as of 6 July 2026.

The profiles

PulsePoint belongs to the WebMD family and brings endemic health inventory; HCP targeting runs NPI-based, DTC through context signals. DeepIntent positions itself through data partnerships and measurement integrations, focused on Rx lift evidence via partners such as Crossix.

The decision grid

Endemic environments and WebMD proximity argue for PulsePoint. Campaigns whose success hangs on prescription-adjacent evidence argue for DeepIntent. Both demand managed proximity and US contract logic; self-serve expectations from generalist programmatic fit neither completely.

For DACH the verdict is the same

Neither has a lawful data foundation here. Teams planning in DACH treat the duel as a US question and build the local campaign on professional portals plus area signals, legal review included.

PulsePoint and DeepIntent, row by row

Figures from our editorial platform assessment, as of 6 July 2026. No commercial relationship with either vendor.

Dimension	PulsePoint	DeepIntent
Platform type	Healthcare DSP	Healthcare DSP
Regions	US	US
Channels	Display, video, CTV	Display, video, CTV, audio
Data foundation	Endemic inventory from the WebMD family	Data partnerships and measurement integrations
HCP identity	NPI-based, DTC through context signals	US registers (NPI) plus US health-data partners
Access	Managed service, no self-serve	Managed service, no self-serve
DACH limit	NPI-based HCP lists have no DACH equivalent	Limited DACH availability, the US data partners have no counterpart

Go deeper

Planning US healthcare programmatic? Measurement design first, seat second.

Healthcare Media Activation Audit →

More from this cluster

Veeva Crossix Measurement: What It Does, What Replaces It HereIn US pharma media, Crossix is the yardstick. The look pays off from DACH too, precisely because the model does not exist here.HCP vs DTC: The Dividing Line in Healthcare MarketingProfessionals and patients are not two segments of one campaign but two legal spaces. Mixing them risks more than waste.DSP Data Activation: Four Routes Into the SeatData sits in the warehouse, campaigns run in the DSP. Data activation is the bridge, and the route you pick decides cost, control and measurability.Third-Party Audiences in DSPs: What Survives the EEAThe data marketplace promises reach at the push of a button. In the EEA that promise has shrunk, and teams that check it plan better.The DSP Data Marketplace, Explained From Both SidesA catalog for buyers, a sales channel for data providers. Both sides underestimate the same thing: the cost chain behind the segment.Geo Audience Data in DSPs: Segment FirstEvery DSP can do geo targeting. Whether it accepts an area segment is a platform question. The data product has to be clean first.

Q01
Which of the two fits US HCP campaigns?
PulsePoint when endemic inventory from the WebMD family counts. DeepIntent when the evidence hangs on prescription-adjacent metrics via partners such as Crossix. Both demand managed proximity and US contract logic, and neither offers self-serve.
Q02
Can PulsePoint or DeepIntent be used in DACH?
Not viably. Both data models rest on US registers and US health-data partners with no local equivalent. Local healthcare reach comes from professional portals plus area signals, legal review per deployment included.